Detail akcie Klaria Pharma Rg online

Business Summary: Klaria Pharma Holding AB (publ) is a Sweden-based holding company engaged in the biotechnology and medical research industry. Through its group subsidiaries, the Company is active in developing and commercializing therapeutic drugs and treatment methods in the fields of migraine and pain related to cancer based on a patented drug delivery platform in the form of an alginate-based polymer film, which facilitates rapid and reliable transmucosal absorption via a muco-adhesive film. The Company operates Klaria Pharma AB as a wholly owned subsidiary.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Klaria Pharma Holding AB (publ) revenues increased from SEK123K to SEK9M. Net loss before extraordinary items increased 7% to SEK30.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Research and Development Costs increase of 66% to SEK15.3M (expense), Administrative costs increase of 60% to SEK10.4M (expense).